Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era.
Pagoni M, Garofalaki M, Panitsas F, Manola K, Psarra K, Economopoulos P, Vourtsi A, Antoniades M, Gkirkas K, Tzouvara E, Katis F, Prokopiou C, Tziotziou I, Balta A, Lemissiou E, Tsirigotis P, Repoussis P, Harhalakis N. Pagoni M, et al. Among authors: panitsas f. Mediterr J Hematol Infect Dis. 2011;3(1):e2011053. doi: 10.4084/MJHID.2011.053. Epub 2011 Nov 28. Mediterr J Hematol Infect Dis. 2011. PMID: 22220250 Free PMC article.
Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
Manola KN, Panitsas F, Polychronopoulou S, Daraki A, Karakosta M, Stavropoulou C, Avgerinou G, Hatzipantelis E, Pantelias G, Sambani C, Pagoni M. Manola KN, et al. Among authors: panitsas f. Cancer Genet. 2013 Mar;206(3):63-72. doi: 10.1016/j.cancergen.2013.01.001. Epub 2013 Feb 12. Cancer Genet. 2013. PMID: 23411131
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Vassilakopoulos TP, Michail M, Papageorgiou S, Kourti G, Angelopoulou MK, Panitsas F, Sachanas S, Kalpadakis C, Katodritou E, Leonidopoulou T, Kotsianidis I, Hatzimichael E, Kotsopoulou M, Dimou M, Variamis E, Boutsis D, Terpos E, Dimopoulou MN, Karakatsanis S, Michalis E, Karianakis G, Tsirkinidis P, Vadikolia C, Poziopoulos C, Pigaditou A, Vrakidou E, Economopoulos T, Kyriazopoulou L, Siakantaris MP, Kyrtsonis MC, Symeonidis A, Anargyrou K, Papaioannou M, Hatjiharissi E, Vervessou E, Tsirogianni M, Palassopoulou M, Gainaru G, Stefanoudaki E, Zikos P, Tsirigotis P, Tsourouflis G, Assimakopoulou T, Konstantinidou P, A Papadaki H, Megalakaki K, Dimopoulos MA, Pappa V, Karmiris T, Roussou P, Panayiotidis P, Konstantopoulos K, Pangalis GA. Vassilakopoulos TP, et al. Among authors: panitsas f. Oncologist. 2021 Jul;26(7):597-609. doi: 10.1002/onco.13789. Epub 2021 Jun 17. Oncologist. 2021. PMID: 33870594 Free PMC article.
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Vassilakopoulos TP, Panitsas F, Mellios Z, Apostolidis J, Michael M, Gurion R, Ferhanoglu B, Hatzimichael E, Karakatsanis S, Dimou M, Kalpadakis C, Katodritou E, Leonidopoulou T, Kotsianidis I, Giatra H, Kanellias N, Sayyed A, Tadmor T, Akay OM, Angelopoulou MK, Horowitz N, Bakiri M, Pangalis GA, Panayiotidis P, Papageorgiou SG. Vassilakopoulos TP, et al. Among authors: panitsas f. Hematol Oncol. 2023 Feb;41(1):97-107. doi: 10.1002/hon.3096. Epub 2022 Dec 8. Hematol Oncol. 2023. PMID: 36314897
Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.
Vassilakopoulos TP, Kravvariti E, Panitsas F, Angelopoulou MK, Liaskas A, Kontopidou FN, Yiakoumis X, Variami E, Dimopoulou MN, Siakantaris MP, Asimakopoulos JV, Arapaki M, Dimou M, Diamantopoulos P, Sachanas S, Chatzidimitriou C, Belia M, Konstantinou E, Boutsikas G, Petevi K, Kanellopoulos A, Kokoris S, Kyrtsonis MC, Viniou NA, Lakiotaki E, Tsourouflis G, Korkolopoulou P, Konstantopoulos K, Panayiotidis P, Pangalis GA. Vassilakopoulos TP, et al. Among authors: panitsas f. Blood Cancer J. 2022 Jul 5;12(7):102. doi: 10.1038/s41408-022-00674-w. Blood Cancer J. 2022. PMID: 35790712 Free PMC article. No abstract available.
Development of Classic Hodgkin Lymphoma after successful treatment of primary mediastinal large b-cell lymphoma: results from a well-defined database.
Vassilakopoulos TP, Piperidou A, Hadjiharissi E, Panteliadou AK, Panitsas F, Vassilopoulos I, Variamis E, Boutsis D, Michail M, Papageorgiou S, Tsourouflis G, Dimou M, Karakatsanis S, Kalpadakis C, Stavroyianni N, Katodritou E, Kotsopoulou M, Kotsianidis I, Verigou E, Hatzimichael E, Leonidopoulou T, Xanthopoulos V, Panayiotidis P, Konstantopoulos K, Dimopoulos MA, Karmiris T, Batsis I, Papaioannou M, Pangalis GA, Angelopoulou MK. Vassilakopoulos TP, et al. Among authors: panitsas f. Leuk Res. 2021 Jan;100:106479. doi: 10.1016/j.leukres.2020.106479. Epub 2020 Nov 16. Leuk Res. 2021. PMID: 33285316 No abstract available.
Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma.
Xagoraris I, Vassilakopoulos TP, Drakos E, Angelopoulou MK, Panitsas F, Herold N, Medeiros LJ, Giakoumis X, Pangalis GA, Rassidakis GZ. Xagoraris I, et al. Among authors: panitsas f. Br J Haematol. 2021 May;193(3):488-496. doi: 10.1111/bjh.17352. Epub 2021 Feb 2. Br J Haematol. 2021. PMID: 33528031 Clinical Trial.
36 results